login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
INFINITY PHARMACEUTICALS INC (INFI) Stock News
USA
- NASDAQ:INFI -
US45665G3039
-
Common Stock
0.0447
USD
-0.04 (-46.98%)
Last: 9/13/2023, 8:17:37 PM
0.04
USD
0 (-10.51%)
After Hours:
9/13/2023, 8:17:37 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
INFI Latest News, Press Relases and Analysis
All
Press Releases
2 years ago - By: The Rosen Law Firm, P.A.
- Mentions:
OTC
INFI DEADLINE TODAY: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Infinity Pharmaceuticals, Inc. Investors to Secure Counsel Before Important October 16 Deadline in Securities Class Action – INFI
2 years ago - By: Bragar Eagel & Squire, P.C.
INFINITY DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Infinity Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm
2 years ago - By: THE ROSEN LAW FIRM, P. A.
INFI DEADLINE ALERT: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Infinity Pharmaceuticals, Inc. Investors to Secure Counsel Before Important October 16 Deadline in Securities Class Action - INFI
2 years ago - By: Pomerantz LLP
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Infinity Pharmaceuticals, Inc. - INFI
2 years ago - By: Bragar Eagel & Squire
INFINITY ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Infinity Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm
2 years ago - By: Faruqi & Faruqi, LLP
INFINITY ONGOING INVESTOR DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Infinity To Contact Him Directly To Discuss Their Options
2 years ago - By: THE ROSEN LAW FIRM, P. A.
INFI IMPORTANT DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Encourages Infinity Pharmaceuticals, Inc. Investors to Secure Counsel Before Important October 16 Deadline in Securities Class Action - INFI
2 years ago - By: Bragar Eagel & Squire
- Mentions:
APLD
FOUR
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Applied Digital, Infinity, and Shift4 and Encourages Investors to Contact the Firm
2 years ago - By: Pomerantz LLP
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Infinity Pharmaceuticals, Inc. - INFI
2 years ago - By: Seeking Alpha
- Mentions:
MEIP
Infinity Pharmaceuticals reportedly files for Chapter 11 (OTCMKTS:INFI)
2 years ago - By: Faruqi & Faruqi, LLP
INFINITY DEADLINE REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Infinity To Contact Him Directly To Discuss Their Options
2 years ago - By: The Rosen Law Firm PA
ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Infinity Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – INFI
2 years ago - By: Bragar Eagel & Squire
- Mentions:
LYV
APLD
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Live Nation, Applied Digital, and Infinity and Encourages Investors to Contact the Firm
2 years ago - By: THE ROSEN LAW FIRM, P. A.
ROSEN, A LONGSTANDING LAW FIRM, Encourages Infinity Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - INFI
2 years ago - By: Faruqi & Faruqi, LLP
INFINITY INVESTOR DEADLINE APPROACHING: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Infinity To Contact Him Directly To Discuss Their Options
2 years ago - By: Bragar Eagel & Squire
- Mentions:
FOUR
CMA
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Infinity, Shift4, and Comerica and Encourages Investors to Contact the Firm
2 years ago - By: Pomerantz LLP
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Infinity Pharmaceuticals, Inc. - INFI
2 years ago - By: THE ROSEN LAW FIRM, P. A.
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Infinity Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INFI
2 years ago - By: Bragar Eagel & Squire
- Mentions:
FOUR
CMA
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Infinity, Shift4, and Comerica and Encourages Investors to Contact the Firm
2 years ago - By: The Rosen Law Firm PA
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Infinity Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – INFI
2 years ago - By: Faruqi & Faruqi, LLP
INFINITY DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Infinity To Contact Him Directly To Discuss Their Options
2 years ago - By: Benzinga
- Mentions:
SCNI
NSTG
JYNT
CELZ
...
12 Health Care Stocks Moving In Wednesday's After-Market Session
2 years ago - By: Pomerantz LLP
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Infinity Pharmaceuticals, Inc. - INFI
2 years ago - By: Benzinga
- Mentions:
MYNZ
WKHS
ACAX
DZSI
...
Why Eiger BioPharmaceuticals Shares Are Trading Lower By 52%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Please enable JavaScript to continue using this application.